Dagmar Chase

Company: Clinrex GmbH

Dr. Dagmar Chase graduated in Computer Science with a secondary focus on Theoretical Medicine at the Technical University in Munich and has a PhD in Human Biology from the Medical Faculty of the University in Ulm, Germany.
Dr. Chase co-founded the company GMI, a full service CRO for clinical trials phase II – IV, in 1983. Besides developing GMI into one of the largest CROs in Germany, Dr. Chase concentrated on Quality Management as well as the development of training programs for the pharmaceutical industry.
In order to be able to offer international services to GMI’s clients she was instrumental in the merger of GMI with the US-based CRO Kendle International Inc in 1997, holding the position of Vice President until the beginning of 2004.
In March 2004 Dr. Chase started up Clinrex, a consultancy firm for clinical research. In addition to providing training and consulting for all aspects of GCP and Quality Management, she focuses on GCP gap analyses and inspection readiness programs, management of DSMBs/DMCs  and project coordination  e.g. helping sponsors to identify and manage the right partners in the EU (legal representation, CROs, etc.). Dr. Chase is President of the German CRO Association BVMA e.V. (Bundesverband Medizinischer Auftragsinstitute) and Vice President of the EU CRO Federation (EUCROF).